Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Sophiris Bio Inc (SPHS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Sophiris Bio Inc historical data, for real-time data please try another search
0.0000 0.0000    0.00%
23/03 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0000 - 0.0000
Sophiris Bio Inc 0.0000 0.0000 0.00%

Sophiris Bio Inc Company Profile

 
Get an in-depth profile of Sophiris Bio Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

6

Equity Type

ORD

Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company’s primary product candidate is PRX302 (topsalysin), which is in Phase III clinical trial for treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. It has a strategic relationship with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of PRX302 for the treatment of the symptoms of BPH, prostate cancer, prostatitis, or other diseases of the prostate; and license agreement with UVIC Industry Partnerships Inc. and The Johns Hopkins University with respect to the use of PRX302 for the development of therapeutics for the symptoms of BPH, prostate cancer, and other non-cancer diseases and conditions of the prostate. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. Sophiris Bio, Inc. was founded in 2002 and is based in La Jolla, California.

Contact Information

Address 1258 Prospect Street
La Jolla, 92037
United States
Phone 858-777-1760
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SPHS Comments

Write your thoughts about Sophiris Bio Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ilan Amir
Ilan Amir Jan 24, 2020 11:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There working on thw korona virus
Brian Crich
Brian Crich Jan 09, 2019 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At these prices I think Big Pharma would love to add Topsalysin to its arsenal.
Radek Holub
Radek Holub Nov 01, 2016 4:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think BO today!!
Mike Chammout
Mike Chammout Aug 01, 2016 5:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't see why it would drop anymore this stock is a hold stock and sit on it until another stage gets approved or shows good result ... I see a great buy opportunity and just be patient
Ali Chammout
Ali Chammout Aug 01, 2016 11:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up or down guys
Matt F
Matt F Jun 13, 2016 2:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I've got 80% of my assets in the short right now, confident it'll keep going down.
Pier-Olivier Marquis
Pier-Olivier Marquis Jun 13, 2016 2:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Confident
Armon Koochek
Armon Koochek Jun 13, 2016 2:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lmfao, so did you die? That pop mistake erased your whole entire account
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email